Biotechnology Analysts JMP discuss what PATHFNDR-2 means for Paltusotine (CRNX) on an Analyst/Industry conference call to be held on March 25.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNX:
- JMP Securities biotech analysts to hold an analyst/industry conference call
- Biotech Alert: Searches spiking for these stocks today
- Crinetics price target raised to $55 from $54 at Oppenheimer
- Crinetics price target raised to $80 from $60 at JMP Securities
- Crinetics price target raised to $60 from $50 at H.C. Wainwright
